The relevance of FcγRs in GBS is implied by some clinical studies showing that certain polymorphisms in activating FcγR genes are associated with risk of developing GBS and severity of the disease [20-22]. The gene discussed is FCGR2A; the disease is Guillain-Barre syndrome.